• About ENEAAbout ENEA
  • Committees 2024-2026
  • Standing Office
  • Prizes
  • Bylaws
  • ENEA Young Researcher Committee
ENEA-logo-RVBENEA-logo-RVB
  • Home
  • Latest News
  • Congresses & Workshops
  • About ENEA
    • Presidential Message
    • Committees 2024-2026
      • Committees 2022-2024
    • Standing Office
    • Prizes
    • Bylaws
    • EYRC
    • ENEA Joint Activities
  • Sponsors
    • ENEA Endorsements
  • EYRC
    • EYRC Corner
    • EYRC Prizes
    • EYRC Videos
    • EYRC Podcasts
    • Courses
  • Membership
  • Resources
    • Newsletters
    • ENEA registry
    • ENEA publications
    • Education – CME
    • Guidelines
    • References
    • Studies
    • Journal Club
    • NERN Webinar
  • Contact
  • My Account
    • Registration
ENEA-logo-RVB
ENEA-logo-RVB

EYRC Training Program: Career in progress, Interview with Dr. Nicole Bechmann

21/02/2025ΕΝΕΑ

We are starting a new series of interviews with early/mid-career investigators! We hope this will help young neuroendocrinologists grow and find inspiration for setting up collaborations.
For our inaugural interview, on behalf of the EYRC, Dr. Cihan Atila interviewed Dr. Nicole Bechmann shortly after the past ESE Summer School, held in Innsbruck, Austria in June 2024.

  • Listen to Spotify Podcast 
  • Listen to Apple Podcast

Research Focus
Dr. Nicole Bechmann investigates adrenal gland tumors and their role in endocrine hypertension disorders such as primary aldosteronism, Cushing’s syndrome, and pheochromocytoma/paraganglioma. Her work explores the interplay between genetics, metabolism, adrenal hormones, and sexual dimorphism to understand tumor formation and progression. Combining clinical studies with basic research, her goal is to improve diagnosis and develop better therapies for adrenal tumors.

Expertise
Dr. Bechmann specializes in adrenal physiology, tumor biology, and catecholamine and steroid metabolism. She utilizes advanced cell line models, including 2D, 3D, and flow-through systems, to study pheochromocytoma, neuroblastoma, and adrenocortical carcinoma. Her work includes gene editing techniques like CRISPR/Cas9 for functional validation of genetic variants, studies of small molecule inhibitors, and investigations into tumor cell metabolism, migration, and invasion. These multidisciplinary approaches aim to advance our understanding of adrenal tumors and identify novel therapeutic targets.

It was a pleasure to interview Dr. Bechmann, and we hope her insights will aid in developing your career! A video format is also available on Youtube! https://www.youtube.com/watch?v=QsCaM5lu-JA

You must be logged in to post a comment.

Follow us on Twitter & Linkedin

Twitter
LinkedIn
YouTube
Instagram
Data PrivacyMy AccountContact
© 2020 All rights reserved.